Related references
Note: Only part of the references are listed.Transitional progressive multiple sclerosis: MRI and MTI findings
M. Filippi et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Primary-progressive multiple sclerosis (vol 6, pg 903, 2007)
D. Miller et al.
LANCET NEUROLOGY (2009)
Primary-progressive multiple sclerosis
David H. Miller et al.
LANCET NEUROLOGY (2007)
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis:: a 3-year follow-up analysis of the BENEFIT study
Ludwig Kappos et al.
LANCET (2007)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky et al.
ANNALS OF NEUROLOGY (2007)
The natural history of multiple sclerosis: a geographically based study - 9: Observations on the progressive phase of the disease
M Kremenchutzky et al.
BRAIN (2006)
Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis
W Brück
JOURNAL OF NEUROLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Is inflammation important in early PPMS? a longitudinal MRI study
GT Ingle et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Long-term clinical outcome of primary progressive MS:: Predictive value of clinical and MRI data
J Sastre-Garriga et al.
NEUROLOGY (2005)
Primary progressive multiple sclerosis
X Montalban
CURRENT OPINION IN NEUROLOGY (2005)
The multiple sclerosis functional composite: different practice effects in the three test components
A Solari et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis
SM Leary et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
The pathology of primary progressive multiple sclerosis
C Lucchinetti et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Immunologic factors in primary progressive multiple sclerosis
R Hohlfeld
MULTIPLE SCLEROSIS JOURNAL (2004)
Grey and white matter atropy in early clinical stages of primary progressive multiple sclerosis
J Sastre-Garriga et al.
NEUROIMAGE (2004)
Progress in deciphering the genetics of multiple sclerosis
BM Herrera et al.
CURRENT OPINION IN NEUROLOGY (2003)
Interferon β-1a in primary progressive MS -: An exploratory, randomized, controlled trial
SM Leary et al.
NEUROLOGY (2003)
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen et al.
NEUROLOGY (2002)
Randomized controlled trial of interferon-beta-1a in secondary progressive MS - MRI results
DKB Li et al.
NEUROLOGY (2001)
Relapses and progression of disability in multiple sclerosis.
C Confavreux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis
PD Molyneux et al.
BRAIN (2000)
Share Paper
